Success Metrics

Clinical Success Rate

100.0%

Based on 7 completed trials

Completion Rate

100%(7/7)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

14%

Ph phase_3

57%

Ph phase_4

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

1(14.3%)

Phase 3Large-scale testing

4(57.1%)

Phase 4Post-market surveillance

2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (14.3%)

Phase 34 (57.1%)

Phase 42 (28.6%)

Trials by Status

completed7100%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_4

Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

NCT00361153

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT03876717Phase 4

Effect of the Sequestrant Colesevelam in Bile Acid Diarrhoea

Completed

NCT00147758Phase 3

WelChol® and Sulfonylurea in Treating Patients With Type 2 Diabetes

Completed

NCT00151749Phase 3

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Completed

NCT00147719Phase 3

WelChol® With Metformin in Treating Patients With Type 2 Diabetes

Completed

NCT00361153Phase 2

Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

Completed

NCT00151762Phase 3

Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes

Completed

NCT00185107Phase 4

Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7